REDX PHARMA PLC has a total of 160 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2004. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are FOURNIER LAB SA, HEPAREGENIX GMBH and TAKEDA PHARMACEUTICALS CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 35 | |
#2 | WIPO (World Intellectual Property Organization) | 25 | |
#3 | Australia | 15 | |
#4 | United States | 13 | |
#5 | Canada | 10 | |
#6 | EPO (European Patent Office) | 10 | |
#7 | China | 9 | |
#8 | Republic of Korea | 6 | |
#9 | Singapore | 6 | |
#10 | Brazil | 5 | |
#11 | Israel | 5 | |
#12 | Mexico | 5 | |
#13 | Philippines | 4 | |
#14 | Hungary | 3 | |
#15 | EAPO (Eurasian Patent Organization) | 2 | |
#16 | New Zealand | 2 | |
#17 | South Africa | 2 | |
#18 | Hong Kong | 1 | |
#19 | Japan | 1 | |
#20 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Peptides | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Steroids | |
#9 | Sugars | |
#10 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Bhamra Inder | 37 |
#2 | Bingham Matilda | 31 |
#3 | Testar Richard | 29 |
#4 | Donoghue Craig | 23 |
#5 | Cooper Ian | 19 |
#6 | Lyons Amanda | 15 |
#7 | Stokes Neil | 15 |
#8 | Armer Richard | 13 |
#9 | Sargent Louise | 13 |
#10 | Guisot Nicolas E S | 12 |
Publication | Filing date | Title |
---|---|---|
GB202100526D0 | Pharmaceutical formulation | |
GB202001344D0 | Ras Inhibitors | |
GB201801226D0 | Modulators of Rho-associated protein kinase | |
GB201704313D0 | Antibacterial compounds | |
WO2017137743A1 | Antibacterial compounds | |
AU2017218556A1 | Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds | |
GB201700484D0 | Modulators of Rho-associated protein kinase | |
GB201700490D0 | Modulators of rho-associated protein kinase | |
GB201616456D0 | Antibacterial compounds | |
GB201616460D0 | Antibacterial compounds | |
WO2017046603A1 | Antibacterial compounds and new uses thereof | |
WO2017046606A1 | Antibacterial compounds | |
GB201613947D0 | Compounds | |
GB201613866D0 | Antibacterial compounds | |
GB201612389D0 | Modulators of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TD02) | |
GB201610412D0 | Antibacterial compounds and a new uses thereof | |
GB201604258D0 | Modulators of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO2) | |
GB201602234D0 | Antibacterial compounds | |
GB201602235D0 | Antibacterial compounds | |
GB201602241D0 | Antibacterial compounds |